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ABSTRACT
The effects of conjugated linoleic acid and berberine supplementation on
markers of oxidant status in broiler chickens
Vincent Dartigue

Selection for rapid growth in poultry can be linked to an exaggerated state of oxidative
stress (reactive oxidative species, ROS). Reactive oxidative species are kept in balance by
endogenous and exogenous antioxidants. Two compounds, conjugated linoleic acid (CLA) and
berberine (BRB) a purified compound from plant root extract have been suggested to ameliorate
antioxidant activity. A ten week study examined the effect of CLA and berberine supplementation
on markers of oxidative stress in poultry. Broiler chickens (n=60) were equally divided into six
groups; a control, a CLA group where half of the regular oil used in a standard was substituted for
a CLA oil mixture of cis-9 trans-11 and trans-10 cis-12 isomers, a berberine group (BRB)
consisting of berberine supplementation (200mg/Kg feed), an allopurinol (ALLO) group
(25mg/kg body weight), a CLA and allopurinol (CLA+ALLO) with the same dose as the CLA and
allopurinol groups and a berberine and allopurinol group (BRB+ALLO) ( 200mg/Kg feed and
25mg/kg body weight, respectively). The allopurinol was added to help induced an oxidative stress
state. Body weight, plasma uric acid, plasma glucose, and relative gene expression of six
endogenous liver antioxidants were measured during the course of the study. Neither berberine nor
CLA had an effect on blood glucose concentration. The addition of allopurinol (ALLO) to the diet
induced an oxidative stress state as measured by a significant reduction in plasma uric acid. There
was a 10-fold increase in the relative mRNA expression of superoxide dismutase 2 and 3 as well
as glutathione 1 and 3 in CLA+ALLO and BRB+ALLO treatment groups. Notably, CLA increased
the expression of uncoupling protein 34-fold compared to control while the addition of allopurinol
blocked these changes. In contrast, there was a slight increase in the BRB+ALLO treatment. No
significant changes were measured in blood glucose. In the case of plasma ceramides, there was
significant decrease in concentration in the redox groups compared to controls. Despite the
increase in mRNA expression of the antioxidants genes, these results suggest that at the dosages
administered, CLA and berberine were not effective in reversing the oxidative stress induced by
allopurinol. Despite the increase in mRNA expression of the antioxidants genes, these results
suggest that at the dosages administered, CLA and berberine were not effective in reversing the
oxidative stress induced by allopurinol.
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Literature Review
Introduction
Inflammation is a vital and crucial part of physiology and the immune system. It is characterized
physiologically by redness, heat, soreness and rashes. At the molecular level, it is broader: from diapedesis
to the chemical reactions and signaling responses involved in the process. The term inflammation can be
further divided into an acute or chronic response. Acute inflammation can be defined as a short and
pronounced response whereas it is sustained in the chronic response; which can be deleterious. Chronic
inflammation has been linked to metabolic syndrome. And the term metabolic syndrome refers to a set of
components such as hyperglycemia, hypertension and hypertriglyceridemia. In a high fat diet, excessive
circulating fatty acids are not taken up by adipose tissue. These circulating fatty acids have signaling
capabilities which have been shown to activate proinflammatory factors as part of the innate immune system
which result in a state of inflammation. This component of the immune response utilizes reactive oxidative
species to destroy foreign or dysfunctional molecules and place the subject in a control and temporary state
f oxidative stress: the production of reactive oxidative species is increased, controlled and used toward a
specific end (Esposito et al., 2004, Sutherland et al., 2004, Serhan et al., 2005, Monteiro et al., 2010).

Reactive Oxidative Species

Reactive oxidative species (ROS) are highly reactive oxygen based molecules. They include molecules
such as superoxide anion (O2-), hydroxyl radical (OH-), hydrogen peroxide (H2O2), nitric oxide (NO),
peroxynitrite (ONOO-) and singlet oxygen (1O2) (Carocho et al. 2013).
From a metabolic point of view, ROS are generated by endogenous and exogenous pathways.
Endogenous ROS are produced by electron leakage from the mitochondria or other organelles such as
peroxisomes, and chloroplast in plants (Apel et al. 2004). Mitochondrial production of ROS starts as an
1

electron leak from the NADH dehydrogenase complex also known as Complex I and the CoQ reductase
complex, complex III of the electron transport chain (ETC), the latter having the highest rate of production
as demonstrated by Qun et al. (2003). If there is a build-up of substrate in Complex I, the rate of electron
transfer from ubiquinone to cytochrome C (Cyt C) in Complex III is reduced as Cyt C can only carry one
electron at a time (Mujahid et al. 2009). As the build-up of substrate continues in Complex I, more electrons
are presented to Complex III. Under normal conditions, the semiquinone would be re-reduced to ubiquinol
by reacting with a proton present in the matrix. However, in the situation where there is an electron leak
(before semiquinone can be reduced), the electron reacts with an oxygen molecule also present in the matrix
creating a superoxide anion. (Albert et al. 2002)
Another source of endogenous ROS production is through a process called “oxidative burst.” This
process is mostly used in host immunity. The oxidative burst involves the generation of hydrogen peroxide
and superoxide by nicotinamide adenine dinucleotide phosphate-oxidase enzyme (NADPH-oxidase, NOX).
NOX is a family of transmembrane proteins involved in the reduction of oxygen to superoxide anion or
hydrogen peroxide based on the homologue or type of activation triggered. The NOX family can be
activated by several factors but its reduction capacity is limited by the amount of available NADPH, the
reducing agent as well as oxygen, the oxidizing agent. (Apel et al. 2004). The production of hydrogen
peroxide is thought to occur mostly when NOX is constitutively activated. Hydrogen peroxide, if left
unchecked, can split and form hydroxyl radical.
Exogenous ROS can also be produced by factors such as radiation and environmental factors such as
chemical oxidants, hyperoxia toxins and chemotherapeutics (Bouzid et al. 2015). Once such
chemotherapeutic is allopurinol. Allopurinol is a purine based analogue of hypoxanthine; it is a potent
inhibitor of xanthine oxidase and thus is used primarily to treat gout in humans. It does so by inhibiting
plasma uric acid (PUA) production, which itself is an antioxidant (Klandorf et al. 1999). It has been
suggested that the long life span of birds compared to other animals of similar size can be associated to the
concentration of circulating UA, which limits tissue damage (Holmes et al. 2001).
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Reduction and oxidation (Redox) reactions are one of the major chemical pathway by which regulation
of biological pathways occurs in cells (Ray et al. 2012). Although ROS generation is considered to be a
byproduct of respiration it is highly regulated and kept in control by antioxidants. Because of the extensive
regulation of ROS production it is not surprising that they can also be used in signaling pathways as second
messengers involved in intracellular signaling (Martin et al. 2002, Foo et al. 2011). ROS messengers have
unusual attributes and properties in the way they go about signaling. In conventional signaling, the substrate
binds its receptor in a non-covalent way, which leads to a response. Reactive oxidative species tend to
create a covalent bond with their target resulting in a modification/structural alteration in the receptor.
Situations where ROS are used as a second messenger, the target is expected to be modified with no
unwanted and unforeseen impact/activity. After the oxidized receptor has generated its response, it’s
degraded in order to prevent collateral damage. However, in the case of unplanned protein, lipid or DNA
oxidation, there is no immediate regulation of these oxidized molecules, thus the structural alteration may
lead to an undesired activity or cell response. For example, the alteration can lead to a change in cell state,
leading to a non-homeostatic cell, which can be characterized by the overexpression of oncogenes,
formation of mutagens and overall increase in inflammation (Martin et al. 2002, Wu et al. 2006, D’Autréaux
et al. 2007, Pisoschi et al. 2015). In the case of an electron leak (and not as second messengers) ROS do
not have specific targets, however, they exhibit an affinity for some types of molecules/patterns. For
example, superoxide anion (O2-) has a high affinity for iron-sulfur clusters (Fe-S); O2- oxidizes the clusters
at a high rate thus preventing their diffusion. All the O2- anions either oxidize a Fe-S cluster, or dismute to
hydrogen peroxide, factors that limit its signaling capabilities. Hydrogen peroxide is much more versatile,
it is uncharged compared to O2- , which allows it to diffuse across membranes and thus can activate a variety
of second messengers (D’Autréaux et al. 2007, Veal et al. 2007). Further, hydrogen peroxide can elicit
different responses dependent on its concentration. For example, Veal et al. (2007) suggested that in
Schizosaccharomyces pombe different levels of H2O2 activate separate transcription responses. In another
case, Sablina et al. (2005) reported that low levels of hydrogen peroxide triggers an antioxidant response
whereas high levels induces apoptosis of the cell by increased expression of pro-oxidants. These limited
3

findings suggest that more research is needed on ROS signaling. However, in the botanical sciences it is
widely accepted that ROS such as hydrogen peroxide and nitric oxide are key molecules involved in
signaling pathways, both in biotic and abiotic factors but with a tight-regulation of antioxidants that limit
the shift towards oxidative stress (Neil et al. 2001).

Oxidative Stress
Oxidative stress arises when the balance between oxidants (ROS) and antioxidants favors the formation
of oxidants (Reuter et al. 2010, Settle et al. 2014). This imbalance can be characterized by a
chronic/sustained state of inflammation. At the molecular level, oxidative stress causes DNA damage, lipid
peroxidation and protein damage. The DNA, lipid or protein loses or gains an unwanted covalent bond
formed by reaction with a ROS. High concentrations of damaged molecules can contribute to the
inflammatory process by directing the cell away from the homeostatic state as seen in neurodegenerative
diseases (Uttara et al., 2009). Another mechanism by which oxidative stress is linked to inflammation is
the build-up of ROS, which activates some transcription factors that in turn leads to the production of
inflammatory cytokines and chemokines. The localized presence of elevated levels of inflammatory
cytokines and chemokines tend to attract macrophages that attack the host cells. Over a period of time,
these factors contribute to chronic disease complications associated with cancer, diabetes or atherosclerosis
for example (Reuter et al 2010). Thus, the concentration of ROS increases in the pancreatic beta cells there
is an increase in macrophage infiltration that overtime causes the destruction of the beta cells effectively
ceasing the production of insulin (Giongo et al. 2011, Sun et al. 2015).
An increase in ROS production is usually the cause of inflammation, which if chronic is causes the
disease itself such as inflammatory bowel disease or even aging. With this predetermined cascade of events;
identifying oxidative stress markers resulting from ROS mediated oxidation represents a useful means of
diagnosis. One classic method is the measurement of lipid peroxidation via thiobarbituric acid reactive
substances, mainly malondialdehyde, which results from the decomposition of lipid peroxide
4

(Papastergiadis et al. 2012). With the development and increased use of mass spectrometry, the greater
sensitivity of the technique has permitted the detection of useful biomarkers.
Ceramides and isoprostanes are 2 categories of lipids that have been linked with oxidative stress
(Bikman et al. 2011). Ceramides are sphingolipids, composed of a sphingosine back-bone attached to a
fatty acid. They are readily present in blood and in every tissue, being a major component of the cell wall.
Their production occurs via 3 major pathways: de novo synthesis, sphingomyelin hydrolysis and the salvage
pathway. The de novo synthesis pathway involves the addition of a serine amino acid to fatty acyl CoA by
the enzyme serine palmitoyltransferase (SPT). The product of this reaction undergoes three further reactions
before being an active ceramide. The other two pathway of ceramide production are through ceramide
recycling. Sphingomyelin hydrolysis is a pathway in which the phosphorylcholine group is hydrolyzed
from the sphingomyelin by sphigomyelinase (SMase). The third means of producing ceramide is through
the salvage pathway where sphingolipids are degraded in lysosome by acidic SMase to generate ceramides.
An increase in circulating ceramides concentration has been positively correlated to stress stimuli and
ROS generation, the primary path of production of ceramides being de novo synthesis, the second being
the salvage pathway (Bikman et al. 2011). Other studies have shown that an increase in circulating ceramide
concentration is associated with decrease insulin sensitivity, thus a decrease in nutrient uptake by the cell
(Evan et al. 2002, Rico et al. 2016). Nutrient uptake and insulin insensitivity are linked by the ability of
ceramide to down-regulate Protein kinase B/Akt. Ceramide can inhibit Akt, a serine threonine protein
kinase, an enzyme that is involved in cell metabolism through the activation of protein phosphatase 2A
(PP2A) which dephosphorylates Akt. Alternatively Akt activity is decreased by ceramides via Protein
kinase C zeta intermediary (PKCζ) (Andrieu-Abadie et al. 2001, Summers et al. 2006, Bikman et al. 2011).
Isoprostanes are endogenous prostaglandin-like (PG) compounds derived from arachidonic acid as a
result of peroxidation with ROS independently of the cyclooxygenase enzyme pathway (COX) (Morrow et
al. 1992, Liu et al. 2009). Isoprostanes are mainly isomers of prostaglandins F2α (PGF2α) that are biologically
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active (Morrow et al 1992, Montuschi et al. 2004). Their measurement is a reliable indicator of oxidative
stress. An increase in isoprostane concentrations is positively correlated with oxidative injury and is not
affected by dietary lipids (Montuschi et al. 2004). Isoprostanes are equally present in both tissue and fluids
and their presence in both tissues and fluid makes for a reliable indicator of oxidative stress (Bessard et al.
2001, Montuschi et al. 2004).
Oxidative stress, as previously discussed, can be initiated by a variety of factors including a positive
energy balance or heat stress, which includes an increase in body temperature and/or poor nutrient uptake
which can be linked to an increase in metabolic activity. Birds are known to naturally have a higher rate of
metabolism, body temperature, blood glucose, and double folded mitochondria, all of which would suggest
an increase in production of ROS compared to mammals. However, birds tend to live longer than mammals
of the same relative body size due to the production of various endogenous antioxidants including uric acid
(Carro et al. 2010).

Antioxidants
Antioxidants (AOx) consist of a diverse range of molecules that limit the oxidation of substrates
(Carocho et al. 2013, Oyewole et al. 2015). From proteins such as superoxide dismutase to simpler organic
compounds, such as uric acid, they are all viewed as scavenger molecules with the ability to form a stable
compound after being oxidized. In normal conditions, AOx are there to maintain balance thus limiting the
shift to oxidative stress status. Just like the oxidants, AOx can be classified as endogenous and exogenous
(Settle et al. 2015, Pisoschi et al. 2015).
Endogenous antioxidants are scavenging molecules/enzymes and include among them superoxide
dismutase (SOD), catalase, glutathione peroxidase (GPX) and uric acid. Their primary purpose is to reduce
ROS to a non-toxic state by functioning alone or working in concert (Larson et al. 1988). Enzymes such
SOD have a metal base as a cofactor, in which is capable of accepting an electron. In the case of SOD, the
metal bases are present in function of the location where SOD is synthesized; for example, iron (Fe),
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cupper/zinc (Cu/Zn) bases are largely found in the cytosol whereas the manganese (Mn) base is mostly
found within mitochondria (Blokhina et al. 2003). SOD accelerates the dismutation of superoxide radicals
to the lesser toxic form, hydrogen peroxide, which is then converted to water and O2 by catalase (Halliwell
et al. 1996, Blokhina et al. 2003).
Another way to reduce oxidants is to donate the electrons in the form of protons. As an endogenous
scavenger, glutathione peroxidase (GPX) works in this fashion. The reaction usually involves two
glutathiones: the thiol group from each glutathione donates the proton which results in the formation of a
disulfide bridge, glutathione sulfide (GSSG). Glutathione sulfide is then recycled/reduced by NADPH via
glutathione reductase (Fang et al. 2002).
Plasma uric acid (UA) although not a protein is considered a potent antioxidant. UA is a product
of purine degradation by way of xanthine oxidase metabolism of hypoxanthine and xanthine (Carro et al
2010, Fabbrini et al 2014). Its antioxidant properties are associated with the enol form of uric acid. After
undergoing tautomerization, hydroxyl groups are produced which then react in the same mode of action as
glutathione by donating protons (Figure. 1). The synthesis of uric acid can be reliably blocked via
allopurinol administration, which offers a means to increase oxidative stress in broiler chickens (Klandorf
et al 2001).
Exogenous antioxidants on the other hand are non-protein based and are mostly found in fruits and
vegetables. Pishoschi et al (2015) suggested that exogenous antioxidant can be divided into four major
classes: two of the four are comprised of vitamin C and E and their variants, while the othe two are
carotenoids and phenolic based compounds that include several subgroups. In addition to these four major
classes other compounds like minerals (selenium), and alkaloids compounds such as berberine may exert
antioxidant properties (Baraboi et al., 1999, Li et al 2014).
Berberine (Figure. 2) is derived from Coptidis Rhizoma and Phellodendri cortex (Kuo et al 2004).
This compound is primarily used as an antidiarrheal in traditional Chinese medicine (Xu et al 2014). In
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addition, it possesses several known pharmaceutical properties which range from anti-cancer effects, to
anti-diabetic and anti-inflammatory effects. It is not only considered to have direct antioxidant properties
but can also elicit an increase in endogenous antioxidant production (Li et al 2014, Liu et al 2015, Xie et al
2015). Berberine has been suggested to increase the activity of AMP activated protein kinase (AMPK)
pathway and to decrease the mitogen activated protein kinase (MAPK) pathway as well as inhibit
cyclooxygenase-2 and the necrosis factor-κB (NF-κB) pathway (Kuo et al. 2003, Lee et al. 2006, Li et al.
2014, Fan et al. 2015).
Several factors have been suggested to limit the effectiveness of Berberine, among them is it rate
of absorption. Berberine is not a readily soluble compound, in fact its solubility and thus its absorption is
inversely related to its purity. Ma et al. (2016) suggested that Coptidis Rhizoma extract is more soluble and
thus readily absorbed when compared to pure berberine. However, the extract is also accompanied by
nanoparticles that offset its effectiveness.
ROS neutralization by antioxidants, although effective, is not the only approach to keep them in
balance. Another mechanism to target them is to decrease the initial production of ROS. Hence, reducing
the electron leak in the ETC, the site of production in the mitochondria by uncoupling protein (UCP),
represents an alternative approach.

Uncoupling protein
Uncoupling protein (UCP) is a transmembrane protein transporter located in the inner membrane
of the mitochondria (Abe et al. 2006). UCP is a member of a family of several homologues, which include
UCP1, UCP2 and UCP3 in humans and are involved in thermogenesis and/or ROS balance by moving
protons across the inner mitochondrial membrane, down their concentration gradient by fatty acid flippase
activity. UCP are activated by free fatty acids (FFA) and inhibited by purine nucleotides in an allosteric
manner (Echtay et al. 2001, Teulier et al. 2001, Diano et al. 2012, Berardi et al. 2014). Nucleotide binding
occurs at the hydrophilic region with the phosphate group near the proline-kinks. The binding sites for FFA
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are located on the outside of the protein, specifically in helix 1 and helix 6 of the transmembrane region.
Fatty acyl chains are positioned in the hydrophobic region of helix 1 and 6 whereas the carboxylate head is
located near the charged region close to the surface of the lipid bilayer. FFA binding to UCP results in a
chemical change in the active site. Protons (H+) within the inter membrane space are translocated to the
inner matrix in a FA-dependent manner with the carboxyl head of the fatty acid used as a proton acceptor.
UCP effectively uncouples respiration (ETC) from oxidative phosphorylation. It selectively
decreases the gradient of protons required by complex V to drive ADP phosphorylation in addition to
increasing the proton gradient in the mitochondrial matrix which decreases the probability of the electron
on semiquinone from reacting with O2 and creating a superoxide anion (Criscuolo et al. 2005). Electrons
are transported as a proton via NADH to complex I and III at which point they reduce ubiquinone (Q) to
ubiquinol (QH2). Ubiquinol cycles through complex III which presents the electron to cytochrome C (Cyt
C) effectively reducing it. Cyt C, however, can only transport one electron at a time, so ubiquinol is partially
reduced to semiquinone. At this point the semiquinone, which carries the electron has two possible paths.
One possibility is that the electron is “leaked” and reacts with O2, which functions as an electron acceptor,
leading to a superoxide anion thus creating reactive oxidative species. A second possibility is that before
the electron is leaked; semiquinone is re-reduced to ubiquinol by reacting with a proton present in the
mitochondrial matrix that was moved from the inter membrane space of the mitochondria to the matrix by
UCP. The ubiquinol can then, undergo a second cycle and present the second electron to Cyt C and proceed
through the ETC (Genova et al. 2014, Baniulis et al. 2016).
UCP1 is mostly found in brown adipose tissue (BAT) with significant role in thermogenesis. A
proton leak in this homologue has been associated with the generation of heat by uncoupling oxidative
phosphorylation from the mitochondrial ETC (Krauss et al. 2005). This process allows energy to be released
as heat. The UCP 2 and UCP3 homologues have been suggested to be involved in a reduction in ROS by
the previously described mechanism. UCP 2 is expressed in several tissues whereas UCP 3 is limited to
skeletal muscle and BAT and WAT (Shabalina et al 2013).
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Overall regulation of the UCP homologues has been linked to the sympathetic nervous system. In
situations where there is a need for an increase in uncoupling activity, β-adrenergic receptors are activated
by catecholamines. This activation leads to an increase in the uptake of fuels by the cells expressing UCP.
The increase in fuels (primarily glucose) leads to an increase production of NADH and FADH2, which is
used to increase the UCP activity.
The thermogenic capacity of UCP makes it a potential target when investigating possible factors in
the treatment of obesity. Different methodologies to treat obesity include the approach of using UCP’s
thermogenic properties. However, obesity can be accompanied by diabetes, which is the absence or
inefficient action of insulin. Herein lies the double edge source of UCP. Krauss et al. (2005) suggested that
UCP can exacerbate insulin production based on the ratio ADP/ATP. As glucose is oxidized, NADH and
FADH2 feed into the ETC which is coupled with oxidative phosphorylation. The increase ATP production
in turn leads to the production/release of insulin. However, when oxidative phosphorylation is uncoupled
from the ETC by UCP, the concentration of ATP produced does not truly represent the state of the host and
so the amount insulin produced is not reflective of the actual energy balance. Thus an insufficient amount
of blood glucose is taken up from circulation which results in a prolonged state of insulin, hyper-secretion
by the β-cells. Ultimately this situation may result in insulin being processed and presented/ treated as a
self-antigen which lead to lymphocytic infiltration of the beta cells.
Avian UCP closely resembles that of the mammalian (approximately 70%) UCP2 and UCP3 in its
affinity and its activation by free fatty acids. Amongst the possible fatty acids available that activate UCP;
it has been suggested that conjugated linoleic acid is a likely candidate (Abe et al., 2006, Mujahid et al.,
20006).

Conjugated linoleic acid
Conjugated linoleic acid (CLA) refers to a group of fatty acids that are 18 carbon long; the term
conjugate is used to describe a mixture of 28 geometric isomers of linoleic acid (Yang et al. 2015). The
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primary source of CLA is from dairy products. Dietary linoleic acid are biohydrogenated by the ruminants’
rumen microbiota, which generates the various isomers. Some of the isomers may than be incorporated into
the animal’s fat or milk. Chemicals synthesis of CLA from safflower and sunflower oils has been
commercialized. Of the 28 conjugated systems, cis-9 trans-11 and trans-10 cis-12 have been shown to be
the forms capable of exerting metabolic effects. However, selection for the two isomers that affect
metabolism is difficult as a mix of conjugated product is normally obtained (Takashi et al. 2002).
Of the two isomers having a metabolic effect, trans-10 cis-12 possesses lipolytic activity; whereas
the cis-9 trans-11 isomer is anabolic and anti-inflammatory. However, both isomers do possess anticarcinogenic properties. Although cis-9 trans-11 is correlated with anti-inflammatory actions; both isomes
possesses some anti-inflammatory properties. It has been suggested that CLA replaces linoleic and
arachidonic acid, consequently reducing the activity of COX and LOX as mediators of inflammation. The
cis-9 trans-11 isomer of CLA has been suggested to diminish the expression of both interleukin 6 and 1β,
as well as the tumor necrosis factor alpha (Radmark et al. 2014; Yang et al. 2015).
Additional studies have investigated CLA’s interaction with peroxisome proliferator activated
receptor (PPAR) and UCP. PPAR a family of transcription factors involved in anabolism that can be
activated by polyunsaturated fatty acids. This family is composed of PPAR α, β, γ1 and γ2. (Ramiah et al.
2014, Viladomiu et al. 2015). The PPAR family are involved in processes such as triglyceride synthesis
and fatty acid uptake by down regulating genes such as lipoprotein lipase and fatty acid synthase as well as
activating fatty acid oxidation. The different homologue have different properties, with PPARα involved in
catabolism, fatty acid oxidation, lipoprotein transport and mostly active in the fasting state. PPARγ on the
other hand is expressed in a fed state and is characterized by lipogenesis and fatty acid transport. PPARβ is
a modulator of PPARγ (Kersten et al., 2000). The PPAR family also possesses anti-inflammatory properties
through various pathway, for example, interaction with NF-κB. Studies by Chen et al. (2014) and Lian et
al. (2015) found that supplementing PUFAs in the diet was correlated with a decrease in markers of
inflammation such interleukin and cytokines but also in NF-κB. It was Hou et al. (2012) who elucidated
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the mechanism showing that the ubiquitination of NF-κB by PPAR, effectively tags it for degradation
(Marion-Lettellier et al. 2016).
Uncoupling protein 1 in humans plays a role in fatty acid oxidation and heat production. CLA has
been linked with an increase in the activity and expression of UCP (Yang et al. 2015, Baraldi et al. 2016).
As it uncouples oxidative phosphorylation, the energy is dissipated as heat. Because ATP concentrations
are not indicative of the energy level, more substrate is sent to the ETC in order to reinstate/restore
homeostasis. One of the sources of substrate are the fat reserves; hence the reduction of body fat associated
with UCP (Yang et al. 2015).

Conclusion and Justification
Selection of fast growing chicken in the poultry industry has led to the generation of broiler
chickens defined by an increased metabolism, capable of generating market standards in an average of six
weeks. Heat stress which has been linked to oxidative stress, defined by increased reactive oxidative
species, is a significant concern as it impacts production and the overall health of the bird (Akbarian et al.
2016; Fellenberg et al. 2006). The use of allopurinol in broiler chicken production has previously been
shown to mimic the heat stress and by association the oxidative stress state with the added possibility of
controlling the severity of the stress (Klandorf et al. 2001, Simoyi et al. 2002, and Settle et al. 2015). With
this background and knowledge, we posited that the use of compounds, such conjugated linoleic acid and
berberine would decrease reactive oxidative species, and thus partially ameliorate the oxidative stress state
induced by allopurinol (Dartigue et al. submitted).

Objective
To determine the effect of CLA and berberine supplementation on markers of oxidant status in
broiler chickens
12

Figures

Figure 1. Uric acid keto-enol tautomerization (adapted from Nimse, 2015)

Figure 2. Berberine and its metabolite (adapted from https://examine.com/supplements/berberine/)

Figure 3. Linoleic and conjugated linoleic acid (https://authoritynutrition.com/conjugated-linoleic-acid/)
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Chapter 1
Abstract
Selection for rapid growth in poultry can be linked to an exaggerated state of oxidative stress (reactive
oxidative species, ROS). Reactive oxidative species are kept in balance by endogenous and exogenous
antioxidants. Two compounds, conjugated linoleic acid (CLA) and berberine (BRB) a purified compound
from plant root extract have been suggested to ameliorate antioxidant activity. A ten week study examined
the effect of CLA and berberine supplementation on markers of oxidative stress in poultry. Broiler chickens
(n=60) were equally divided into six groups; a control, a CLA group where half of the regular oil used in a
standard was substituted for a CLA oil mixture of cis-9 trans-11 and trans-10 cis-12 isomers, a berberine
group (BRB) consisting of berberine supplementation (200mg/Kg feed), an allopurinol (ALLO) group
(25mg/kg body weight), a CLA and allopurinol (CLA+ALLO) with the same dose as the CLA and
allopurinol groups and a berberine and allopurinol group (BRB+ALLO) ( 200mg/Kg feed and 25mg/kg
body weight, respectively). The allopurinol was added to help induced an oxidative stress state. Body
weight, plasma uric acid, plasma glucose, and relative gene expression of six endogenous liver antioxidants
were measured during the course of the study. Neither berberine nor CLA had an effect on blood glucose
concentration. The addition of allopurinol (ALLO) to the diet induced an oxidative stress state as measured
by a significant reduction in plasma uric acid. There was a 10-fold increase in the relative mRNA
expression of superoxide dismutase 2 and 3 as well as glutathione 1 and 3 in CLA+ALLO and BRB+ALLO
treatment groups. Notably, CLA increased the expression of uncoupling protein 34-fold compared to
control while the addition of allopurinol blocked these changes. In contrast, there was a slight increase in
the BRB+ALLO treatment. No significant changes were measured in blood glucose. Despite the increase
in mRNA expression of the antioxidants genes, these results suggest that at the dosages administered, CLA
and berberine were not effective in reversing the oxidative stress induced by allopurinol.
Key words: allopurinol, antioxidants, broiler, ceramide, oxidative stress,
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Introduction

Inflammation is of significant concern in the poultry industry, it impacts production worldwide and
the overall health of the chicken. Inflammation can arise from both environmental and internal factors, the
former can be usually traced back to an increase in ambient temperature. The latter has a broader range of
origin from species to gender and metabolism. Both environmental and internal factors are characterized
by an increase in oxidative stress (Cerruti et al., 1993, Federico et al., 2007, Fellenber et al., 2006).
Oxidative stress results from an imbalance between reactive oxidative species (ROS), which are highly
reactive oxygen base molecules, and antioxidants (AOx). A major source ROS is the electron transport
chain (ETC) (Chen et al., 2012, Murphy et al., 2009) and in an imbalance state they represent a danger to
aerobic organisms because of their high reactivity and tendency to form covalent bonds with lipids, proteins
and DNA (Martin et al., 2002, Wu et al., 2006, D’Autréaux et al., 2007). Any structural alterations in
molecules can lead to a change in cell state, distancing itself from cell homoeostasis, which can be
characterized by overexpression of oncogenes, formation of mutagens, and overall inflammation (Pisoschi
et al., 2015).
Birds in general have higher level of plasma glucose than mammals which simulates/mimics a
constant state of hyperglycemia. They, however, do not exhibit any noticeable side effects observed in
mammals with similar concentrations. This is prevented by an elevated levels of plasma uric acid. Plasma
uric acid is a potent Aox for circulating ROS in species lacking uricase. Previous studies in poultry have
demonstrated that allopurinol supplementation reduces plasma uric acid concentrations thus establishing a
controllable oxidative stress model (Simoyi et al., 2002). In a normal state, ROS generation is balanced by
antioxidants and other molecules having AOx like properties, which target and neutralize the oxidative
species. Antioxidants can be characterized as endogenous or exogenous. The main families of endogenous
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Aox are the superoxide dismutase and the glutathione family while the exogenous ones are mostly
characterized by the presence of a phenol group (Pisoschi et al., 2015, Larson et al., 1987).
Berberine, an exogenous Aox isolated from plant root extract, has been used in traditional Chinese
herbal medicine. This compound is a quaternary ammonium salt that possesses several benzene rings and
methoxy functional groups, which allows the electron to circulate within the conjugated double bond
system. In addition to increasing the activity of endogenous antioxidants, berberine is reputed to possess
anti-diabetic, anti-inflammatory and anti-carcinogenic properties (Meeran et al., 2008, Li et al., 2014, Liu
et al 2015, Xie et al., 2015). Neutralization of ROS may also be achieved by activation uncoupling protein
(UCP). Uncoupling protein is a member of the family of the transmembrane proteins located in the inner
membrane of the mitochondria homologues involved in thermogenesis and ROS balance. Its main mode of
action is to uncouple respiration (ETC) from oxidative phosphorylation and it does so by moving protons
from the inner mitochondrial membrane space into the matrix (Teulier et al., 2001; Abe et al., 2006). This
action increases the probability of any pair of protons of reacting with superoxide radicals, thereby, creating
metabolic water from catalase or glutathione peroxidase. Berardi et al. (2014) has suggested that UCP can
be activated by the binding of fatty acid (C14 to C18) to the receptor whereas purine nucleotides act as
allosteric inhibitors. For example, trans-10 cis-12 conjugated linoleic acid (CLA) has been shown to affect
energy balance through up-regulation of UCP activity (Abe et al., 2006, Mollica et al., 2014, Viladomiu et
al., 2015, Yang et al., 2015). CLA refers to a collective of fatty acids, each 18 carbons long. The primary
source of CLA is from dairy products and beef, lamb and goat fat by hydrogenation of dietary linoleic acid
and stearic acid. Of the 28 conjugated isomers, the cis-9 trans-11 and trans-10 cis-12 are produced in the
greatest quantity and were shown to have the most prominent metabolic effects. The purpose of this study
was to determine if the addition of berberine or CLA to the diet of broiler chicken could reverse the
induction of an oxidative stress state induced by allopurinol. We hypothesized that the addition of the two
compounds should increase the endogenous antioxidants possibly reverting the redox state induced by the
help of the allopurinol.
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Material and Methods
All procedures and experiments were approved by West Virginia University’s Institution Animal Care and
Use Committee (ACUC #15-0301.1).

Experimental Design
Three study were conducted, two preliminaries and the main study. The two preliminary (prelim)
studies were conducted using forty five and seventy mixed sex day old Cobb/Cobb 500 broiler chicks,
respectively. In the main study, sixty mixed sex day old Cobb/Cobb 500 broiler chicks were used. All chicks
were obtained from Pilgrim’s Pride, Moorefield, WV. Chicks were housed within pens and maintained
under a twelve hour light-dark cycle with temperature set at 27°C. For the first two days after hatch, chicks
were kept in the same pen with a heating lamp. On the third day, chicks were divided in two pens until they
reached one week of age, at which time they were tagged with leg bands and divided into six pens based
on weight. The chicks were kept on a starter diet for the first four weeks. At week five of the study, the
broiler chickens were started on different treatments (see Table 1).

Preliminary study 1 treatments
The first preliminary study lasted for a total of nine weeks was composed of 4 groups. The 4 treatments
were composed of a control diet, a berberine diet (BRB) supplemented with berberine (100mg/kg of feed)
(Li et al 2014), a conjugated linoleic (CLA) diet as explained in the main study. The last diet was a
combination of berberine and CLA (BRB+CLA) which mirrored the BRB and CLA treatments. For the
second preliminary study, the design registered four groups of eight chicks with replicates.

Preliminary study 2 treatments
For the second preliminary study, the design registered four groups of eight chicks with replicates and also
lasted nine weeks. The second preliminary study 2 was composed of a control diet, a berberine diet (BRB)
supplemented with berberine (200mg/kg of feed), an allopurinol diet (ALLO) given at a dose of 25mg/kg
body weight (Klandorf et al., 2001) and the last diet was a combination of berberine and allopurinol
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(BRB+ALLO) which mirrored the BRB treatments with the addition of allopurinol (25mg/kg of body
weight) for the last week of the study. Groups four five through eight were treated with allopurinol to help
induce a redox state (Settle et al., 2012). Weights were recorded weekly over the five weeks of experimental
period. Berberine (prelim 1: chloride, purity >99%, prelim 2: chloride hydrate, purity >99%), the CLA, and
the allopurinol for the respective studies were purchased as stated in the main study.

Main Study treatments
The main study lasted for ten weeks and was composed of a control group, a CLA group in which half of
the regular oil used in the normal diet was substituted for a mixture of 50/50 cis-9 trans-11 and trans-10
cis-12 isomers CLA oil (1.1% CLA oil diet) (Ramiah et al 2014). Group 3 (BRB) was supplemented with
berberine (200mg/kg of feed) (Li et al 2014), group 4 (ALLO) was given allopurinol (25mg/kg of body
weight) (Klandorf et al 2001), group 5 (CLA+ALLO) and 6 (BRB+ALLO) mirrored the CLA and BRB
treatments with the addition of allopurinol (25mg/kg of body weight) for the last two weeks of the study.
Groups four five and six were treated with allopurinol to help induce a redox state (Settle et al 2012).
Weights were recorded weekly over the six week experimental period. Berberine (chloride hydrate, purity
>99%) and Allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). The CLA was
purchased commercially (Vitamorph Labs, Highland, IN, USA) as 1200 mg capsules. Food and water were
provided ad libitum.

Sampling procedure
After two weeks on treatment, in all three studies blood samples (4ml) were obtained from six birds per
pen from the brachial (wing) vein. Each sample was transferred to a heparinized tube and immediately
placed on ice. The same birds were sampled for the next three bleedings: for a total of four bleedings. Once
the samples were collected they were centrifuged at 2000 rpm for 20 minutes at 4°C to collect plasma. They
were stored at -20° C, pending analysis. On the last day of the study, the birds were euthanized and a sample
of liver (~1g) was snap frozen in liquid nitrogen until stored in a -80°C freezer for further analysis.
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Sample analysis
Plasma samples in the -20°C were used for measurement of plasma glucose and plasma uric acid.
Plasma glucose was measured using amperometric measurement of hydrogen peroxide (H2O2) on a
platinum electrode (YSI 2700 Biochemistry analyzer) (Hall et al., 1998, Klandorf et al., 2001). Plasma uric
acid (PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent assay from Thermo Scientific
(Waltham, MA, USA; Klandorf et al 2001).
Liver samples (75-100 mg) were used to study the relative mRNA expression of six antioxidant related
genes in the superoxide dismutase (SOD) family, glutathione (GPX) family and uncoupling protein (UCP)
family. A Trizol-Reagent (Invitrogen™, Carlsbad, CA) based method was used to extract and isolate total
RNA. The isolated RNA was resuspended in nuclease free water and treated with DNase (Ambion®,
Thermo Scientific Waltham, MA, USA). Four microliters of DNase treated RNA were reverse transcribed
to cDNA utilizing an iScript™ cDNA synthesis kit from Bio-Rad (Hercules, CA). A SYBR® Green Master
Mix kit (Bio-Rad, Hercules, CA) method was used on a BIORAD CFX96 Real Time System (C1000 Touch
Thermal cycler) to quantify the expression of SOD1, SOD2, SOD3, GPX1, GPX3 and avUCP using
designed

primers.

The

gene
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and

sequences
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http://bioinfo.ut.ee/primer3-0.4.0/primer3/) (see Table 2). Results of real time PCR were normalized to the

housekeeping gene GAPDH. Calculation and analysis of mRNA expression was performed using the
efficiency corrected delta-delta Ct method (Barnes et al., 2012).

Sampling procedure and sample analysis
The sampling procedure again followed the main study with the exception of the addition of the
resolving medium (Mono-Poly, MP biomedicals, LLC Solon, Ohio) was added, in a 1:1 ratio, to separate
the leukocytes in both preliminary studies. Half of the sample were transferred to a new tube where a
resolving medium (Mono-Poly, MP biomedicals, LLC Solon, Ohio) was added, in a 1:1 ratio, to separate
the leukocytes. All the samples were centrifuged at 2000 rpm for 20 minutes at 4°C to collect plasma and
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leukocytes. The plasma samples were stored at -20° C, pending analysis. The leukocytes were transferred
to micro centrifuge tube and place on ice for immediate analysis. No liver samples were taken.
The analysis was the same with the exception of oxidative stress measurement. Oxidative stress
was measured using L-012 (8-Amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4-(2H,3H)dione
Sodium Salt) base chemiluminescence techniques (Van Dyke et al 1987, Klandorf et al 2001). The
leukocytes were activated using a phorbol 12-myristate 13-acetate (pma) (Sigma Saint Louis, MO, USA).

Statistical analysis
In preliminary studies, the effects of experimental treatments on bodyweight, plasma uric acid,
plasma glucose and oxidative stress measurements were analyzed using ANOVA with treatment as main
effect. Tukey’s multiple comparison test was used for specific pair wise comparison.
In the main study, the effects of experimental treatments on bodyweight, plasma uric acid, and
plasma glucose and gene expression were analyzed using ANOVA with treatment as main effect. Tukey’s
multiple comparison test was used for specific pair wise comparison. Statistical analysis for gene expression
was done on ΔCt, however, the ΔΔCT measurement were used in the figures. The values presented are the
LSM+SE. Statistical analysis was done using JMP program (SAS Institute Inc., Cary NC). Statistical
significance was set at P < 0.05.

Results
Preliminary Studies
In short, in the first preliminary study there was a significant difference between control and the
BRB+CLA group body weight, 2.45 kg and 1.95 kg respectively. In the second preliminary study, there no
differences to report. End point plasma uric acid analysis revealed in the first prelim a significant decrease
PUA in the BRB and BRB+CLA groups compared to controls, 0.30, 0.36 and 0.48 mM, respectively; in
the second, we observed a significant decrease in all treatments compared to controls. The control had a
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PUA concentration of 0.44 mM whereas the other 3 treatments averaged around 0.35mM. In reactive
oxidative species analysis, BRB group was significantly lower when compared to control.

Main study
There was no significant differences in body weight (BW) gain between the treatments. For plasma
uric acid analysis, there was a significant (P < 0.05) decrease in plasma uric acid concentrations towards
the end of the study in groups administered allopurinol compared to the control (Fig 1). The decrease was
more pronounced (P < 0.05) in the CLA+ALLO and BRB+ALLO groups, 0.17mM and 0.16mM
respectively, compared to both ALLO (0.27mM) and controls ( 0.43mM). Neither berberine nor CLA had
a measurable effect on plasma glucose concentrations (Table 2). In the BRB group, there was a significant
decrease in liver/bodyweight ratio compared to controls (Fig 2). Allopurinol administration in ALLO,
CLA+ALLO and BRB+ALLO groups increased (P < 0.05) the liver/BW ratio as compared to the controls,
Fig 2. However, CLA+ALLO and BRB+ALLO led to a numerical decrease in liver/bw ratio compared to
ALLO group.
The relative expression of superoxide dismutase (SOD) 1 through 3, uncoupling protein (UCP) and
glutathione (GPX) 1 and 3 are shown in Fig 3. The genes were chosen based on their location and their
targets. SOD 1 and 3 uses Cu/Zn as electron acceptors and were expressed in the outer mitochondrial
membrane and in the cytoplasm, respectively. SOD2 has manganese as an electron acceptor and is located
in the mitochondrial matrix. GPX 1 and 3 differed base on their location, intracellular and plasma soluble
respectively. Only one homologue of UCP was studied. Control unit were expresses as arbitrary units and
set as 1. In the non-redox state, CLA led to a 4 fold increase in SOD1, whereas BRB slightly decrease
SOD1 expression below controls (Fig 3, A). The ALLO group increased SOD1 expression by 3 fold, which
was not significant. The redox state, however, caused by allopurinol led to a 6 and 12 fold increase (P <
0.05) in both CLA+ALLO and BRB+ALLO.
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SOD2 expression across treatments was comparable to the changes observed in SOD1 (Fig 3, B).
In the non-redox state, CLA increased SOD2 six fold, whereas BRB increased the expression two fold.
However, SOD2 expression decreased in ALLO group in contrast to the increase observed in SOD1. CLA
and BRB, when exposed to allopurinol led to an increase in expression of SOD2. CLA+ALLO also
significantly increased SOD2 relative expression by 7 and BRB+ALLO by 16 fold (P < 0.05). In contrast
to SOD1 and SOD2, SOD3 expression in CLA, BRB and ALLO groups were not significantly different
compared to the controls (Fig 3, C). The redox state, however, increased expression of SOD3 in
CLA+ALLO and BRB+ALLO, at 10 and 9 fold, respectively.
A marked increase in uncoupling protein (UCP3) expression occurred in response to the CLA
treatment (34 fold increase) whereas BRB marginally affected UCP expression (3 fold increase) when
compared to controls (Fig 3, D). UCP3 expression decreased in the ALLO group as compared to control.
In contrast to CLA, CLA+ALLO only increased UCP expression 4 fold whereas there was a 10 fold increase
in UCP3 expression in the BRB+ALLO group.
Glutathione1 (GPX1) expression was similar to that observed in the SOD3 group (Fig 3, E). In the
non-redox state, CLA and BRB did not undergo significant changes in expression. In the redox state, ALLO
did not change the expression of GPX1, whereas CLA+ALLO and BRB+ALLO treatments led to a 9 and
10 fold increase (P < 0.05), respectively. Glutathione 3 (GPX3) expression closely resembled that of SOD
2 in both the non-redox and redox state (Fig 3, F). There was a small increase in GPX3 expression in the
CLA and BRB groups, as well as in the allopurinol treated birds. CLA+ALLO and BRB+ALLO modulation
were pronounced with increase expression of 5 and 11 fold, respectively (P < 0.05).

Discussion and Conclusions
Plasma uric acid is a potent antioxidant in birds and its inhibition has been linked to an increase in
ROS production in chicken (Settle et al., 2012 & 2015). Previous studies have established that allopurinol
is a potent inhibitor of plasma uric acid in chicken which leads to a redox state in the chicken (Klandorf et
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al., 2001, Simoyi et al., 2002). The degree or severity of the redox state can be varied depending on the
dosage of allopurinol administered, resulting in a somewhat controllable model of oxidative stress for redox
study. Making use of this model, we set out to test to determine if berberine and/or CLA could restore the
bird to its pre-redox state caused by the administration of allopurinol.
One week after administration allopurinol, PUA declined in all treated groups. By week 10, the
ALLO group had a level of plasma uric acid of 0.27mM compared to the control, 0.40 mM. However, this
decline was unexpectedly more pronounced in both the CLA+ALLO and BRB+ ALLO groups as they
reached levels of 0.17 and 0.16mM respectively (P < 0.05). Kong et al (2004) suggest that berberine may
have an inhibitory effect on xanthine oxidase; if so this would explains the negative synergistic effect on
the plasma uric acid level.
CLA is known to increase the activity and expression of UCP (Takahashi et al., 2002) whereas
berberine is suggested to reduce blood glucose concentration in Type 2 diabetes by increasing insulin
sensitivity (Xing et al., 2011) as well as enhance the expression of endogenous antioxidants such as SOD
(Li et al., 2014). UCP is a transmembrane protein with its active site exhibiting flippase activity to move
protons. The accumulation of protons in the matrix increases the probability that a proton interacts with an
electron as they cycle through complex III and IV. As the animal transitions from a normal to redox state,
there should be an increase in antioxidants to neutralize the ROS and potentially dampen the effect of the
shift. With this basic premise, the addition of these compounds was expected to increase the expression of
antioxidant genes. To test this hypothesis, we measured the mRNA expression of six endogenous
antioxidants genes. Berberine administration led to an increase in the relative expression of SOD 1, 2 and
3 by 13, 16 and 8 fold respectively. These compounds also improved mRNA expression of UCP, glutathione
1 and 3, by a 10 fold change in both UCP and GPX1 and an 11 fold change in GPX3. Although, CLA was
hypothesized to affect UCP, it also increased the relative expression of other endogenous antioxidants,
albeit less pronounced. Comparable results were reported by Cantwell et al. (1999) in human cell line
exposed to cow milk containing CLA.
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Reactive oxyegen are kept in balance by antioxidants. The superoxide dismutase (SOD) family and
glutathione are among the principal endogenous antioxidants. SOD catalyzes superoxide to hydrogen
peroxide, which is then degraded to in water and oxygen by glutathione (Halliwell et al., 1996). Overall,
for the SOD family, CLA led to a 7, 6 and 8 fold increase in SOD 1, 2 and 3, respectively. Cellular
glutathione’s expression increased by 9 fold whereas the increase in extracellular glutathione was 5 fold.
However, the addition of CLA to allopurinol did not result in further increase in UPC expression.
Allopurinol is a purine analogue which may have inactivated UCP, which is down-regulated by purines. It
is possible that allopurinol also masked the effect of CLA on UCP. This would explain the 3 fold increase
in the redox state in contrast to the 34 fold increase in UCP expression without allopurinol. Furthermore
CLA modulation of UCP expression could be an additional means to maintain ROS balance
An increase in ROS has been linked to liver inflammation due to the recruitment of inflammatory
cells. ROS signaling leads to leukocytes infiltration which in turn leads to additional ROS production
(Greenhalgh et al., 2015). In the current study, we measured an increase in liver size in the ALLO group as
well as an increase in the liver to BW ratio as compared to controls. The addition of the BRB and CLA to
the allopurinol treated birds was able to numerically decrease liver weight but not back to control levels.
These results are in agreement with Hwang et al. (2002) who observed in rats that berberine decreased ROS
production and the incidence of liver lesions by an increase glutathione production. The results suggest that
at the dosages used in this study CLA and berberine were not able to completely restore to a non-redox
state in birds administered allopurinol.
The data gathered in the preliminary studies were used to draw conclusion in parallel with our main
study. The use of the allopurinol redox model in birds to study the effect of CLA and berberine on markers
of oxidative stress was not conclusive. The liver to BW ratio suggested that the addition of CLA and
berberine were able to partly reduce the inflammation of the liver but not to control levels. A further
reduction in plasma uric acid by these two compounds to allopurinol fed birds was not anticipated, which
suggest that additional ROS may have been produced. CLA and berberine were able to increase the relative
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mRNA expression of the selected endogenous antioxidant genes but without measurement of the gene
product, we do not know if these changes have been translated/expressed. Finally, at the dosage of
allopurinol used we were not able to completely revert the redox state. We conclude that the allopurinol
model can be used to measure the ability of alternative compounds to ameliorate the induced oxidative
stress.

Figures
Figure 1. Change in plasma uric acid (mM) over the course of the last four weeks of treatments. The vertical

dashed line represents the time at which allopurinol was added for allopurinol supplemented treatments.
The non-redox state is shown as solid lines in contrast to the redox state represented by dotted lines. The
values represent mean and standard errors (P <0.05)

Figure 2. Relative mRNA expression of hepatic endogenous antioxidants enzyme in broiler chickens. (A,

B and C) Increase expression of superoxide dismutase (SOD) 1 through 3 in the CLA+ALLO and
BRB+ALLO groups relative to control. (D) Effect of treatments on uncoupling protein (UCP3) expression.
(E and F) Increase in Glutathione 1(GPX1) and GPX3 expression across treatments. Data expressed as
mean and standard errors. The data was calculated using the δ-δ Ct method. GAPDH was used as a
housekeeping gene to normalize. The asterisk indicate a significant difference from control (P < 0.05).
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Table 1. Ingredient and percentage composition of diet fed to broilers
Item
CLA oil
Ingredient %
Control Diet
Diet
Soybean meal
28.3
28.3
Corn
66.2
66.2
Regular oil
2.2
1.1
CLA
N/A
1.1
Dicalcium phospate
1.7
1.7
Calcium carbonate
0.8
0.8
Salt
0.25
0.25
Nutra blend mixa
0.25
0.25
Methionine
0.2
0.2
Monensin
0.1
0.1
Total %
M. Energyb (kcal/kg)
3130.5
3130.5
Protein %
19.5
19.5
Fat %
4.9
4.9
Fiber %
2.67
2.67
Calcium %
0.78
0.78
Phosphorous % (total)
0.67
0.67
Phosphorous %
(avalaible)
0.44
0.44
Methionine %
0.48
0.48
Methionine + Cysteine %
0.82
0.82
Lysine %
1.04
1.04
a
Nutrablend premix is from Premix NB 3000 used at a rate of five lbs/ton Nutra Blend LLC (Neosho,MO)
consisted of manganese (4%); zinc (4%); iron (2%); copper, 4.500ppm; iodine, 600ppm; selenium, 60ppm;
vitamine A, 1.4E10e5 IU/lb; vitamin D3, 5.E5 IU/lb; vitamin E 3.E3 IU/lb; vitamin B12, 2mg/lb;
menadione, 150mg/dl; riboflavin, 1200mg/dl; thiamine, 200mg/dl; D-pantothenic acid, 1200mg/dl; niacin;
5000mg/dl; vitamin B6 250mg/dl; folic acid 125mg/dl; choline, 700000mg/dl; Biotin 6mg/dl.
b
Metabolisable energy
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Table 2. Oligonucleotide primers for real-time RT-PCR
Gene

Forward (5'-3')

Reverse (5'-3')

Annealing (°C)

Accession Number

GAPDH

gagggtagtgaaggctgctg

cggatcaaaggtggaagaat

60

NM_204305.1

GPX1

ggaggctctgcagtaaagga

cttcgaggctttggaagatg

60

NM_001277853.2

GPX3

gagatcctccctgcactgaa

cacatcccctttctggaaga

60

NM_001163232.2

(Cu-Zn)SOD1

tgctggacctcgtttagctt

ctcatttcccactgccatct

60

NM_205064.1

(Mn)SOD2

aatggtgggggtcatatcaa

agtcacgtttgatggcttcc

60

NM_204211.1

(Cu-Zn)SOD3

tgtgatccatgagcaggaag

gtttgccagcatttccattt

60

XM_015285700.1

avUCP

gagaaacagagcgggatttg

ctcctggctcacggatagag

60

NM_204107.1

1

GPX is Glutathione
a
SOD2 is mitochondrial superoxide dismutase using manganese(Mn) as an electron acceptors
b
SOD 1 and 3 are soluble and extracellular respectively, using Copper-Zinc (Cu-Zn) as electron acceptor

Table 3. Plasma glucose at the beginning and last week of sampling
Treatment
CON
CLA
BRB
ALLO
CLA+ALLO
BRB+ALLO

Bleed 1
mM
11.5±0.45
12.9±0.45
12.0±0.45
12.80.45±
12.0±0.45
12.2±0.45

Bleed 4
mM
12.4±0.30
12.0±0.30
12.6±0.30
12.9±0.30
12.7±0.30
12.6±0.30
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Figure 1. Change in plasma uric acid (mM) over the course of the last four weeks of treatments

Figure 2. Relative mRNA expression of markers of oxidative stress in liver of chickens
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Chapter 2
Abstract
Ceramides have been linked with oxidative stress in humans and dairy cows. In the poultry
industry, changes in ceramide overtime and under oxidative stress state if not well known. Two
compounds, conjugated linoleic acid (CLA) and berberine (BRB) a purified compound from plant
root extract have been suggested to ameliorate antioxidant activity. A ten week study examined
the effect of CLA and berberine supplementation on markers of oxidative stress in poultry. Broiler
chickens (n=60) were equally divided into six groups; a control, a CLA group where half of the
regular oil used in a standard was substituted for a CLA oil mixture of cis-9 trans-11 and trans10 cis-12 isomers, a berberine group (BRB) consisting of berberine supplementation (200mg/Kg
feed), an allopurinol (ALLO) group

(25mg/kg body weight), a CLA and allopurinol

(CLA+ALLO) with the same dose as the CLA and allopurinol groups and a berberine and
allopurinol group (BRB+ALLO) ( 200mg/Kg feed and 25mg/kg body weight, respectively). The
allopurinol was added to help induced an oxidative stress state. Body weight, plasma uric acid,
plasma ceramide C16:0, C18:0, C20:0, C22:0 C24:0, saturated and total ceramides were measured
in a time dependent manner in control and treatment effect of week 6 using GC/MS. The addition
of allopurinol (ALLO) to the diet induced an oxidative stress state as measured by a significant
reduction in plasma uric acid. There was a negative correlation (r = -0.60) between the increase
in body weight and the decrease in plasma ceramides (C16:0, C18:0 and C20:0) concentrations in
control chicks. There was a decrease (P<0.05) in plasma ceramides (C20:0, C22:0 and C24:0) in
chicks supplemented with allopurinol when compared controls. The addition of allopurinol as a
mean to induce oxidative stress unwittingly affected the liver, which potentially affected the results
of plasma ceramide in the oxidative stress state.
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Introduction
Compared to mammals, birds have a higher metabolism, blood glucose concentrations,
body temperature as well as doubled folded mitochondria. They also have lower concentrations of
insulin compared mammals (Witthow et al., 1999 ). Despite an increase in potency of chicken
insulin compared to porcine (Simon et al., 1974), studies in birds have also revealed that the
concentration of insulin receptors varies from tissue to tissue with muscle expressing the lowest
concentration (Simon et al., 1977). These observations suggest that birds are in a constant state of
insulin resistance (Simon et al., 1978). Birds, however, do not exhibit the classic symptoms
associated with hyperglycemia observed in mammals, due to their elevated plasma uric acid
concentrations, a potent antioxidant (Simoyi et al., 2002). Previous studies in poultry have
established that allopurinol (an antagonist of xanthine and hypoxanthine in the purine degradation
pathway) administration induced a redox state with an increase in inflammation associated with
an increase in ROS (Simoyi et al., 2002) and proinflammatory factors (Settle et al., 2015). The
severity of the redox state can be potentially adjusted by increasing dosages of allopurinol
administrated (Simoyi et al., 2002). This supplementation of allopurinol in broiler chickens
induces an “inflammatory state” without a “specific disease” which effectively creates a model in
which to study diseases in which inflammation is predominant (e.g. Diabetes, atherosclerosis).
Ceramides (Cer) are sphingolipids composed of a sphingosine back bone attached to a fatty
acid, and have long been thought of as inert component waxy lipids (Wertz et al., 1983). The acyl
moiety attached to the sphingosine back bone can vary in length (16 to 24 carbons), the fatty acid
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attached is mostly dictated by the ceramide synthase homologues (1-6) involved (Bir). However,
in recent years, it was discovered that they exert a variety of metabolic effects. Amongst these
metabolic effects, ceramides represent a reliable biomarker of oxidative stress in mammals
(Andrieu-Abadie et al., 2001, and Cutler et al., 2002). In humans, Cutler et al. (2002) linked the
death of motor-neuron in amyotrophic lateral sclerosis (ALS) with an increase in ceramide
accumulation in the membrane wall, which renders the cell increasingly vulnerable to oxidative
stress. In dairy cows, Rico et al. (2015) established a relationship between elevated plasma
ceramides (Cer C20:0 and C24:0) and prolonged insulin resistance in peripartal dairy cows. If left
unchecked, the ceramides down regulated protein kinase B (Akt), a second messenger in the
insulin pathway, which placed the cow at increased risk of developing metabolic diseases
(Summers et al., 1998 and Rico et al., 2015). The measurement of ceramides as an early biomarker
of oxidative stress could thus be beneficial to the poultry industry.
As a potential marker of oxidative stress, we measured the changes in plasma ceramides
after allopurinol administration as well as the ability of two compounds, conjugated linoleic acid
(CLA) and berberine (BRB), to potentially increase antioxidant (Aox) activity/expression in
response the induced inflammatory state. Conjugate linoleic acid, a family of 18 carbon
unsaturated fatty acids, is involved in the neutralization of ROS via the uncoupling of the oxidative
phosphorylation complex in the ETC by uncoupling protein (UCP) (Echtay et al. 2001, Teulier et al.
2001). Uncoupling protein is a transmembrane protein located in the inner mitochondrial

membrane. Studies of UCP have provided a mechanism by which unsaturated fatty acids (C14 to
C18) enhance their activity and expression. Overall, UCP raises the proton gradient in the inner
membranes, which increases the probability of any unpaired electrons to react with a proton, which
prevents the formation of oxygen radicals (Diano et al. 2012, Berardi et al. 2014). The second
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compound, berberine, is an alkaloid compound isolated from plant root extract with exogenous
Aox activity. This compound possesses several benzene rings, which allows the electron to
circulate within the conjugated double bonds. In addition to being an exogenous AOx, BRB has
been proposed to increase endogenous AOx expression and exert anti-inflammatory properties (Li
et al., 2014).
In view of the rapid growth rate of broilers, we hypothesized that (1) ceramide
concentration should increase in broiler chickens during a production cycle (2) and that the
addition of allopurinol should further should increase this production. To our knowledge, this the
first time that specific species of plasma ceramides have been measured in birds. (3) Compounds
which exhibit antioxidants properties, such as conjugated linoleic acid and berberine, are
hypothesized to reduce the redox state induced by allopurinol and therefore decrease or lower the
concentration of ceramides as compared to the allopurinol supplemented group (negative control).

Materials and Methods

All procedures and experiments were approved by West Virginia University’s Institution Animal
Care and Use Committee (ACUC #15-0301.1).
Experimental Design
Sixty mixed sex day old Cobb/Cobb 500 broiler chicks were obtained from Pilgrim’s Pride,
Moorefield, WV. Chicks were housed within pens and maintained under a twelve hour light-dark
cycle with temperature set at 27°C. One week after hatch, chicks were divided into six groups and
tagged with a leg band. The chicks were maintained on a starter diet for the first four weeks. At
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week five of the study, the broiler chicks were started on their respective treatments (see Table 1,
in Dartigue et al (submitted)): a control group, a CLA group in which half of the regular oil used
in the normal diet was substituted for a mixture of 50/50 cis-9 trans-11 and trans-10 cis-12 isomers
CLA oil (1.1% CLA oil diet) (Ramiah et al., 2014). Group 3 (BRB) was supplemented with
berberine (200mg/kg of feed) (Li et al 2014), group 4 (ALLO) the diet was supplemented with
allopurinol (25mg/kg of body weight) (Klandorf et al., 2001), group 5 (CLA+ALLO) and group 6
(BRB+ALLO) mimicked the CLA and BRB treatments with the addition of allopurinol (25mg/kg
of body weight) for the last two weeks of the study. The negative control (ALLO), CLA+ALLO
and BRB+ALLO were supplemented with allopurinol to help induced a state of oxidative stress
(Simoyi et al., 2001, and Settle et al., 2012). Berberine (chloride hydrate, purity > 99%) and
allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). The CLA was
purchased commercially (Vitamorph Labs, Highland, IN, USA) as 1200 mg capsules. Food and
water were provided ad libitum.
Sampling procedure

Blood samples were obtained from the brachial wing vein of six birds per pen at week three
of treatment. Each sample was placed in a heparinized tube and stored on ice. The blood samples
were centrifuged at 2000rpm for 20minutes at 4°C. Plasma sample was then transferred to microcentrifuge tube and stored in a -80° C freezer pending analysis.
Sample analysis
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Plasma free fatty acids concentration was measured using an enzymatic colorimetric
methods (HR Series NEFA-HR, Wako chemicals USA Inc., Richmond VA). Plasma uric acid
(PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent assay from Thermo
Scientific (Waltham, MA, USA; Klandorf et al., 2001). Ceramide were extracted using a modified
Bligh and Dyer with a C12:0 Ceramide internal standard (Avanti Polar Lipids, Alabaster, AL).
Extraction and measurement of ceramide were as described in Rico et al. (2015). Concentrations
of plasma ceramides C16, 18, 20, 22 and 24 were measured.
Statistical Analysis

The statistical program SAS (version 9.3; SAS Institute Inc., Cary, NC) was used to
analyze the data. Both time and treatment effects were analyzed. The time-dependent data were
studied as repeated measures and run as a mixed model. Weeks were considered as a fixed effect
whereas birds were treated as random effect. A generalized linear model was used to study the
treatment effect at week 10 of the study. The method of Kenward-Roger (1997) was used to
calculate the degrees of freedom for the denominator. A measure of dependence in both time and
treatment effects was performed using a Pearson’s contingency coefficient. Values are expressed
as least square (LSM) ± standard error (SE) unless stated otherwise. Statistical significance was
set at P < 0.05 and 0.01.

Results

There was a significant increase in body weight in controls (BW) over the last four weeks
of the study (Figure 1, A). Plasma uric acid concentrations in controls remained constant around
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0.4mM, although a slight but significant (P = 0.055) increase was noted between weeks 5 and 6 of
the study (Figure 1, B). In controls, non-esterified free fatty acids stayed leveled around 200 μM
during weeks 3 to 5 of the study before significantly (P< 0.05) falling to 100 μM (Figure 1. C).
Plasma ceramides C22 and C24 were observed to have the highest concentrations at ~ 900
and 1000 ng/ml, respectively (Figure 1, D). These were followed by plasma ceramide C16 with a
concentration around 200 ng/ml (Figure 1, E). Plasma ceramides C18 and C20 were the least
expressed with concentrations ranging from 30 to 70 ng/ml (Figure 1, F). The different species of
plasma ceramide followed the same decreasing trend throughout the 4 weeks (Figure 1). Plasma
Cer C16, C18, C20, C22, C24, as well as total saturated and total ceramides decreased (P < 0.05)
between weeks 3 and 5. However, at week 4 Ceramides C20, C22, C24, total saturated and total
ceramides had significantly increased compared too weeks 3 to 5, restoring approximately 60% of
the original values (Figure 1, D, F and G). There were no significant changes was observed in
ceramide C16 and C18 between weeks 5 and 6 (Figure 1, E and F). Notably, Cer C16, C18 and
C20 concentrations were negatively correlated (r = -0.57) with the increase in BW.
There were no treatment effects on BW (Figure 2, A), which was comparable to plasma
Cer C18 concentration albeit, numerical differences were noted in the redox groups (Figure 2, B).
Non-esterified free fatty acids measurements revealed a significant (P <0.05) increase in
concentrations in all treatments compared to controls (Figure 2, C). There was a significant
decrease in the plasma C16 ALLO group while only numerical decreases were noted in the
CLA+ALLO and BRB+ALLO groups compared to controls. Of note, the CLA+ALLO group was
significantly higher than the ALLO group (Figure 2, D). Plasma ceramide species C20, C22, C24,
saturated and total ceramides decreased significantly (P < 0.05) in the allopurinol supplemented
groups compared to controls (Figure 2, B, E and F). A positive correlation (r = 0.50) between
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PUA (Figure 2, G) and plasma ceramides C22, C24 and total ceramides behavior was also
determined.

Discussion and Conclusions

Ceramides are sphingolipids that have been positively associated with oxidative stress and
metabolic diseases in mammals (Andrieu-Abadie et al., 2001, and Cutler et al., 2002) but their role
in birds has not been established. A redox state in birds can be induced by a variety of factors,
amongst them allopurinol (Klandorf et al., 2001, Simoyi et al., 2002), with a shift towards
prooxidants which can be detrimental. Previous research has demonstrated that allopurinol can
reduce liver uric acid production by inhibiting liver xanthine oxidase (Simoyi et al., 2002, Carro
et al., 2009, and Settle et al., 2012). The decrease in PUA, a potent antioxidants in birds, can lead
to state of oxidative stress characterized by overall inflammation but also liver inflammation
(Carro et al., 2009, Settle et al., 2015). In addition, Carro et al. (2009) determined that various
doses of allopurinol could change the severity of the redox state, effectively creating a somewhat
controllable model of oxidative stress. We made use of this model to investigate plasma ceramides
in broiler chickens. Changes in plasma ceramide concentrations were first determined during the
growth phase and in response to different treatments.
Measurement of plasma ceramides in control birds over the course of 4 weeks revealed an
overall significant decline in plasma ceramides although between week 5 and 6 some species
significantly increased (C22:0 and C24:0) whereas others (C16:0, C18:0 and C20:0) remained
depressed. These results did not support our initial hypothesis, as plasma ceramide concentrations
increased with age in broiler chicks as has been observed in other species (Lightle et al., 2000).
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These observations may result from a decrease in the growth rate/metabolic rate observed at 5
weeks of age in broiler chickens as has been previously described (Kuenzel et al., 1977). Schols
et al. (1996) suggested that an increase in basal metabolic rate was associated with an increase in
the inflammatory state in humans as indicated by the increase in inflammatory markers. Hence,
the downturn in metabolic rate and decrease in oxygen (O2) consumption is suggested to parallel
the decrease in plasma ceramides concentrations. If the downtrend was prolonged past week 5 of
age as measured by Kuenzel et al. (1977) this would support the negative correlation (r = -0.57)
observed between the increase in body weight and the decrease in plasma ceramide concentrations.
The liver is primary organ for free fatty acid synthesis in birds (Whittow et al., 1999).
Ceramide synthesis occurs via the addition of a fatty acid moiety to a sphingosine back bone via
ceramide synthase (Bikman et al., 2011). In this study, non-esterified fatty acids concentrations
were relatively constant until a significant decline (P < 0.05) was observed between weeks 5 and
6, with this decrease reciprocally paralleling the increase in plasma ceramides during this same
period. Watt et al. (2012) demonstrated that ceramide synthesis was dependent on substrate
availability rather than liver serine palmitoyltransferase (SPT) activity. These results suggest that
a fraction of avalaible free fatty acids may have been shuttled towards ceramide synthesis, while
free fatty acids levels were not restored to their original levels. As ceramides are markers of
oxidative stress and positively correlated with inflammation characterized by ROS production
(Andrieu-Abadie et al., 2001, Villena et al., 2007), this scenario could also account for the increase
(P < 0.055) in PUA, a potent antioxidant, during that period.
The induction of an inflammatory state by allopurinol was evident by the significant
decreases in plasma uric acid. However, (2) plasma ceramides in the allopurinol fed groups did
not increase as predicted, rather there was a significant decrease in most species measured. The
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inflammatory state is associated with an increase in protein synthesis as observed in rats, including
various inflammatory proteins such as interleukins and their counterparts (anti-inflammatory and
antioxidants proteins) (Birch et al., 1986, Vary et al., 1992, Knight et al., 2005) . This increase in
liver protein synthesis coupled with the decrease in feed intake caused by allopurinol may have
contributed to the decrease in plasma ceramides concentrations. Comparably, serine amino acids,
which are required for ceramide synthesis, could be redirected towards protein synthesis as well
(Birch et al., 1986, Vary et al., 1992). Schreiber et al. (1982) demonstrated that a labeled pool of
liver leucine in rats was incorporated into plasma proteins, for up to 3 days after the challenge as
result of inducing inflammation.
NEFA were significantly elevated in all treatments compared to controls. This increase in
NEFA may be a result of the inclusion of CLA, BRB and allopurinol in the diet. BRB has been
suggested to inhibit adipogenesis in mammals, (Choi et al., 2006, Hu et al., 2010) which could
explain the observed increase in NEFA. Conjugated linoleic acid is known to increase the rate of
lipolysisin adipose tissues, which would explain the increase in circulating fatty acids
(REFERENCE). Although similar results were observed in Moulard ducks (hybrid of Muscovy
and Pekin ducks) (Felser et al., 2013); a decrease in total hepatic NEFA (which would suggest a
decrease in serum NEFA) was observed in chickens fed CLA (Ko et al., 2004). Previous studies
in ApoE KO mice supplemented with 10μM of allopurinol for 4 weeks revealed a numerical
increase in serum NEFA, which was suggested to be the result of allopurinol inhibiting the uptake
of low density lipoprotein (LDL) into macrophages. In a second study the authors increased the
expression of xanthine oxidoreductase in cell cultures which increased LDL uptake in macrophage
cells resulting in foam cell formation (Kushiyama et al., 2012). The combined synergistic effect
of BRB+ALLO would explain the difference (P = 0.0504) in NEFA observed between the BRB
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and BRB+ALLO groups. However, only a numerical increase in NEFA was noted in the
CLA+ALLO group compared to CLA.
Both plasma ceramide C16 and C18 in controls and treatments were the least changed
compared to the other ceramides species. There was a significant linear decrease in C16 and C18
in controls. However, there was a numerical decrease in C16 and C18 concentrations when
challenged with allopurinol. Ceramides C16 and C18 have been linked to insulin resistance. Turpin
et al 2014 demonstrated that an increase in Cer C16 further aggravated the insulin resistance state
in mice. In a study where Ceramide synthase 6 (CerS6) knockout mice were used to investigate
the absence of Cer C16, the authors observed a decrease in the ceramide C16 coupled with an
improvement in insulin sensitivity and an increase energy expenditure. If Cer C16:0’s metabolic
effects were comparable to avian species, the concentrations measured in the present study might
help to explain why birds are in a constant state of hyperglycemia. In addition, Ceramide synthase
(CerS) 6 and 5 (producers of Cer C16:0 and C18:0) are equally expressed in a greater number of
tissues than Cers 2 and 4 (producers of Cer C20:0- C24:0) which are mostly expressed in liver and
kidneys (Grösch et al., 2011). If this pattern of expression is similar in birds, this might explain
the decrease in plasma ceramides C20 to C24 in the broiler chickens fed allopurinol.
Measurement of ceramide in broiler chickens as markers of oxidative stress is feasible as
they have already been correlated with oxidative stress and ROS production in other species. In
addition, treatments for some ceramide specific associated diseases have already been devised. In
human patients with amyotrophic lateral sclerosis (ALS), the authors observed an increase and
accumulation of Cer C16 in neurons which resulted in the death of the neurons. They also
demonstrated that treatment with the antibiotic myroicin, an inhibitor of SPT, resulted in a decrease
in Cer 16 accumulation in cells (Culter et al., 2002). A provisional analysis of ceramides in
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growing broiler chickens, revealed a deecline towards the end of the growth phase (weeks 2 to ~8
of age) (Kuenzel et al., 1977). Under conditions of oxidative stress, most species of ceramides are
decreased, however, this may be an indirect consequence of inducing the inflammatory state. The
use of allopurinol although practical specifically targets the liver which in birds, is the primary
organ for fatty acids synthesis. For this reason, ceramide production might have been unwittingly
affected by the addition of allopurinol. Alternative methods to induce an oxidative stress state
challenge should be investigated to corroborate the findings of this study.
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Figure 1. Changes in plasma ceramides, PUA, NEFA and weight in control birds over time
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Figure 2. Treatment effects on body weight, plasma ceramides, PUA and NEFA

Figure 1. Plasma concentrations of (A, B, C, and D) ceramides, (E) NEFA, and (F) plasma uric acid in control broiler
chickens over-time. Overall for panel A, B, C and D there was a significant decrease in plasma ceramide
concentrations over the course of the first three weeks (7, 8 and 9) of bleed. In A, there was increase although not
significant in C16 ceramide compared to the previous week. The same pattern was observed in panel B for C18
ceramide. In the case of C20 ceramide (also B), there was significant increase from the 9th to the 10th weeks, this
pattern was also observed in C24 and C22 ceramide (C) and saturated and total ceramides (D). There was decrease in
NEFA (E) with a significant decrease observed from week 9 to 10. For plasma uric acid, the concentration were pretty
similar until week 9; between week 9 and 10, there was significant increase. P < 0.05.
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Figure 2. Body weight (A), plasma ceramide concentrations of (B,D,E,F) ceramide, (G) uric acid and (B) NEFA, of
broiler chicken on week 10 of treatment. Panel A represent the body weight, there were no significant changes to
report. (B) There were no significicant differences in plasma ceramide 18, in constrast all the groups supplemented
with ceramide C20:0 were significantly decrease compared to controls. (C)The measurement of NEFA revealed a
significant increase in all groups compared to control In panel D, there was a significant decrease in C16 ceramide in
the allopurinol group compared to control and a significant difference between ALLO and the CLA+ALLO group. In
addition, a numerical decrease in the CLA+ALLO and BRB+ALLO group was noted. Panel E and F followed the
same pattern, there was a significant decrease in plasma ceramides and plasma uric acid concentrations in the ALLO,
CLA+ALLO and BRB+ALLO groups compared to control. The notation a represents significance compared to control
whereas b compares to the ALLO group. P < 0.05
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